Overview
VBL Therapeutics
?
Bennett M. Shapiro
See more contacts
Medical and Diagnostic Laboratories
,
Ambulatory Health Care Services
,
Health Care and Social Assistance
,
Medical laboratories
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Nursing Care Facilities (Skilled Nursing Facilities)
,
Offices of Dentists
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
?
Actual
?
Actual
#
Actual
? %
?
?
?
?
Contacts
Get in Touch with 6 Principals*
-
Bennett M. ShapiroChairman
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of ? (12 month period) in USD
Annual Revenue 2022
?
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Net Operating Cash | -$32 | -$25 | -$23 |
| Net Investing Cash | $27 | -$15 | $10 |
| Net Financing Cash | $0 | $49 | $17 |
| Net Change in Cash | -$4 | $9 | $4 |
| Cash at Beginning of Period | $22 | $14 | $10 |
| Cash at End of Period | $18 | $22 | $14 |
| Capital Expenditure | -$1 | -$1 | -$0 |
| Assets (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $18 | $22 | $13 |
| Accounts Receivable | $ | $ | $0 |
| Inventories | $ | $ | $ |
| Other Current Assets | $4 | $33 | $19 |
| Asset Summary | |||
| Total Current Assets | $22 | $55 | $32 |
| Tangible Fixed Assets | $7 | $9 | $9 |
| Intangible Assets | $ | $ | $ |
| Total Assets | $30 | $65 | $42 |
| Liabilities (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $1 | $4 | $2 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $6 | $6 | $5 |
| Liability Summary | |||
| Total Current Liabilities | $7 | $10 | $7 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $ | $0 | $0 |
| Total Liabilities | $7 | $12 | $11 |
| Stakeholder's Equity (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Equity | |||
| Common Stock | $0 | $2 | $0 |
| Retained Earnings | -$294 | -$262 | -$232 |
| Equity Summary | |||
| Total Equity | $22 | $52 | $31 |
| Shares Outstanding | 69,750,117 | 69,326,950 | 48,187,463 |